Navigation Links
Global PET SPECT Market (Positron Emission Tomography) & SPECT (Single Photon Emission Computed Tomography) to be US$ 10.3 Billion by 2015
Date:11/10/2010

Global PET SPECT Market (Positron Emission Tomography) & SPECT (Single Photon Emission Computed... -- DALLAS, November 10, 2010 /PRNewswire/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Medical Equipment, Medical Pharmaceuticals, New Products & Services, Surveys, Polls and Research Click to view news release full screen  

Global PET SPECT Market (Positron Emission Tomography) & SPECT (Single Photon Emission Computed Tomography) to be US$ 10.3 Billion by 2015

 

DALLAS, November 10, 2010 /PRNewswire/ -- The report analyzes the PET SPECT Market ( http://www.marketsandmarkets.com/Market-Reports/pet-market-98.html) by technologies and applications and studies the major market drivers, restraints, and opportunities for the PET SPECT market in U.S., EMEA, and Asia-Pacific.

Browse market data tables and in-depth TOC on Advanced PET (Positron Emission Tomography) & SPECT (Single Photon Emission Computed Tomography) Global Market (2010 -2015)

Early buyers will receive 10% customization of reports. http://www.marketsandmarkets.com/Market-Reports/pet-market-98.html

Propelled by the transparent reimbursement policies, new emerging economies, novel applications such as Alzheimer's and continually expanding oncology application segment, the global positron emission tomography (PET) market is estimated to reach around $6.3 billion in 2010.

Reimbursement plays a major role in the adoption of any medical imaging technology. The approval of PET scanning reimbursement in the U.S. by the Medicare and Medicaid for the Alzheimer's disease widened the opportunities for the major market participants. Currently, there are approximately 4.7 million Alzheimer's patients in the U.S. PET enables the radiologist to have the early diagnosis of the Alzheimer disease among the patients. Therefore, this would further increase the demand of the PET scanners among the various health care centers.

Similarly, single photon emission computed tomography (SPECT) scanners have been on the forefront to bring about significant changes in the diagnostic imaging equipment landscape by opening up numerous lucrative opportunities in niche market such as neuroendocrine tumor imaging. Moreover, technological advancements such as attenuation correction and image acquisition/reconstruction tools have enhanced SPECT end users' confidence in its diagnostic and prognostic capabilities. The global PET SPECT market is expected to grow from an estimated $6.5 billion in 2010 to $10.3 billion in 2015, at an estimated CAGR of 9.4% from 2010 to 2015. The PET segment is estimated to account for the largest share - i.e. 75% - of the overall PET SPECT installations at 3,691 units in 2010. This segment is expected to reach 6,390 units in 2015, at a CAGR of 11.6% for the same period.

The PET/CT segment accounted for the largest share - i.e. 97% - of the overall PET market at an estimated $6.1 billion in 2010. This segment is expected to reach $ 9.8 billion in 2015, at a CAGR of 9.8% for the period 2010 to 2015. Oncology and cardiology are the most significant applications of the PET SPECT market. Oncology accounts for about 90% of the PET market, whereas cardiology accounts for about 85% of SPECT application market. Neurological application of PET and SPECT is a niche market and is dependent on the development of appropriate radionuclides and tracers.

Scope of the report

This research report categorizes the global PET SPECT market on the basis of technology, application, and geography; forecasting revenues and analyzing trends in each of the following submarkets:

- On the basis of technology: - Stand alone PET, PET/CT, stand alone SPECT and SPECT/CT - On the basis of application: - Oncology, non small cell lung cancer, Hodgkin and non Hodgkin lymphoma, head and neck cancer, colorectal cancer, breast cancer; cardiology and neurology - On the basis of geography: - U.S., EMEA (Europe, Middle East and Africa), Asia-Pacific and Rest of the world

About MarketsandMarkets

MarketsandMarkets (M&M) is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.

M&M covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports, please visit our website http://www.marketsandmarkets.com

Contact: Ms. Sunita 7557 Rambler Road Suite 727, Dallas, TX 75231 Tel: +1-888-989-8004 Email: sales@marketsandmarkets.com http://www.marketsandmarkets.com http://marketsandmarkets.wordpress.com/ http://marketsandmarkets.blogspot.com/
'/>"/>

SOURCE MarketsandMarkets
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
2. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
3. Directors Forum: PEPFAR and the Global AIDS Response
4. Alfacell Corporation to Present at UBS Global Life Sciences Conference
5. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
6. Global HIV Vaccine Enterprise Names Alan Bernstein as Inaugural Executive Director, Opens New Secretariat
7. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign
8. Hillary Clinton Pledges Bold Approach to Stopping HIV/AIDS & Global Poverty
9. IBA and Elekta Initiate Global Particle Therapy Program at ASTRO
10. Dr. Rajeev Venkayya Joins Gates Foundation as Director of Global Health Delivery
11. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)...  BTL Aesthetics today announced the release of ... ME device was effectively redesigned for more efficient, ... tissue. The result: Significantly better outcomes in abdominal ... ME versus BTL Vanquish. "We are ... patients with the most highly-advanced devices on the ...
(Date:12/6/2016)... Dec. 6, 2016   Sienna Biopharmaceuticals, ... dermatology and aesthetics company, today announced it ... specialty pharmaceutical company focused on developing first-in-class ... including psoriasis, atopic dermatitis and pruritus (itch). ... will make an undisclosed upfront payment in ...
(Date:12/6/2016)...  Arcturus Therapeutics, Inc. ("Arcturus" or the "Company"), ... it entered into collaboration with Takeda Pharmaceutical Company ... of NASH and other gastrointestinal (GI) related disorders, ... UNA Oligomer chemistry. The financial terms were not ... and expertise in GI disorders, we are confident ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... December 07, 2016 , ... A quote from Dr. ... of comments on social media that offer a rare glimpse into the mind of ... authority and New York Times bestselling author, has described people with ADHD as having ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... consultation services from offices located in South Lyon, Dewitt, Williamston, East Lansing, Ann ... basketball coach who needs treatment for a brain tumor. , Jason Bauer and ...
(Date:12/7/2016)... ... 07, 2016 , ... A. Kevin Spann Insurance, a New York-based firm offering ... is launching a charity drive to raise funds that will benefit the Marine Corps ... marines and Navy FMF Corpsmen. Working closely with the MCL, the A. Kevin Spann ...
(Date:12/7/2016)... ... December 07, 2016 , ... Delete® - Tattoo Removal and ... The Holiday Party Season. Save Up To 33% Off Botox® and Juvederm® Products Now ... the Phoenix Valley with Delightful Deals on Botox® and Juvederm® just in ...
(Date:12/7/2016)... ... December 07, 2016 , ... Gensuite is ... Awards under the Best New Product Launch category. Gensuite’s entry on their EZ ... , BOC Global Events & Training Group is a professional event and training ...
Breaking Medicine News(10 mins):